CareValidate Launches Expanded HRT Offering
CareValidate expanded its HRT offering for telehealth companies, combining hormone therapy with provider access, pharmacy services and AI-powered care coordination.
Perimenopause Anxiety: Sometimes It’s a Progesterone Deficiency
Perimenopausal anxiety isn't simply in our patients' heads. It's often the result of complex physiologic changes involving hormones, sleep, metabolism, and the nervous system.
presented by
Closing the Quality-Affordability Gap in Workplace Mental Health
In an interview, Kyan Health Co-Founder and Chief Commercial Officer Konstantin Struck discussed how Kyan gives mid-market and enterprise employers access to premium workforce mental healthcare, at a price point that is affordable.
Menopause Is an Overlooked Driver of Cost in High-Risk Populations
For someone already managing chronic disease, menopause can disrupt stability and complicate treatment plans in ways that aren’t always immediately visible but show up over time in outcomes and utilization.
The Truth About Testosterone in Women: What Medicine Has Overlooked
Testosterone is not just a “male hormone.” Women need it too. And pretending otherwise has left countless women struggling through midlife while being told everything looks “normal.”
MedCity FemFwd: Inside Winona’s New Women’s Health Research Initiative
In this episode, we’re joined by Dr. Cathleen Brown, medical director of menopause company Winona. We discuss the company’s new Winona Research Initiative, which seeks to fund and support menopause and women's health research.
Winona Launches Menopause Research Initiative
Winona launched a new research initiative to fund and support menopause and women's health research.
presented by
Automation Didn’t Dehumanize Care. Bad Systems Did.
We have the opportunity to design systems that give people greater capacity for the work where human presence matters most: listening, understanding, reassuring, deciding, and caring.
presented by
MedCity FemFwd: The Complicated History Behind Hormone Replacement Therapy
In this episode, we’re joined by Janna Manjelievskaia, director of health economics and outcomes research at Veradigm. We discuss Veradigm’s recent Women’s Health Insights Report, which highlights the complicated history around Hormone Replacement Therapy (HRT), a medication used to treat menopause.
Carrot Expands AI Metabolic Health Program to Menopause
Carrot is expanding its AI-powered metabolic health program to support menopause care, offering personalized guidance and wearable integration.
presented by
The Power of Real World Data to Study Women’s Health at Scale
A new report from Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
Digital Health’s Latest Unicorn: Why Investors Are Backing Midi’s Model for Women’s Health
Virtual women’s health provider Midi Health has reached unicorn status after raising a $100 million Series D, with investors backing its insurance-covered, direct-to-consumer model. The company is positioning itself as a long-term, virtual “hospital without walls” designed to meet women’s health needs across midlife and beyond.
presented by
Inside an Automated Healthcare Practice: Redesigning Care Around People, Not Paperwork
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
NIH-Backed Startup Amissa Unveils AI Platform to Improve Menopause Care
NIH-backed startup Amissa has launched an AI-powered platform that aggregates data from multiple sources to improve how menopause and perimenopause are tracked and treated.
FDA Will Remove Warnings for HRT Products Used for Menopause
The FDA will remove black box warnings on hormone replacement therapies after evidence showed the risks were overstated.
Bayer Menopause Drug Lands FDA Approval, Bringing Competition to an Astellas Product
Bayer’s Lynkuet, approved for treating moderate-to-severe vasomotor symptoms of menopause, targets two receptors key to temperature regulation. The once-daily pill came from Bayer’s 2020 acquisition of KaNDy Therapeutics.
Millie Introduces Perimenopause and Menopause Program
With Millie's new perimenopause and menopause offerings, patients receive treatments like hormone therapy, non-hormonal medications, vaginal treatments and lifestyle strategies for symptom relief.
WeightWatchers Introduces New Menopause Program
WeightWatchers' new menopause program provides support from menopause-trained clinicians, along with workshops, fitness guidance and access to prescriptions when needed.